Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2204]

Tucatinib authorised by UK’s MHRA for locally advanced or metastatic HER2-positive breast cancer

Tucatinib authorised by UK’s MHRA for locally advanced or metastatic HER2-positive breast cancer

Medication-based starvation of cancer cells

Medication-based starvation of cancer cells

New data from the phase 3 CLEAR trial demonstrate significant improvement in progression free survival and overall survival versus standard of care in advanced renal cell carcinoma

New data from the phase 3 CLEAR trial demonstrate significant improvement in progression free survival and overall...

FDA grants accelerated approval to umbralisib for marginal zone lymphoma and follicular lymphoma

FDA grants accelerated approval to umbralisib for marginal zone lymphoma and follicular lymphoma

FDA approves cemiplimab-rwlc for locally advanced and metastatic basal cell carcinoma

FDA approves cemiplimab-rwlc for locally advanced and metastatic basal cell carcinoma

Evidence for routine brain tumour imaging is murky, but research can shed light

Evidence for routine brain tumour imaging is murky, but research can shed light

Global survey reveals heavy toll of COVID-19 first wave on liver cancer care

Global survey reveals heavy toll of COVID-19 first wave on liver cancer care

World Cancer Day: Energy and persistence conquer all things - Dr Matti Aapro

World Cancer Day: Energy and persistence conquer all things - Dr Matti Aapro

ECO: Europe’s beating cancer plan: inspiring us to rise above challenges, together!

ECO: Europe’s beating cancer plan: inspiring us to rise above challenges, together!

Providing inclusive care for LGBTQ2SPIA cancer patients

Providing inclusive care for LGBTQ2SPIA cancer patients

More from ecancer